Vaccination against human papillomavirus (HPV) is recommended for young women to protect them from HPV infection and cervical cancer. Male HPV immunization is increasingly a topic of debate in the medical community. A timely review of the literature published in Viral Immunology explores whether HPV vaccination of young men is warranted and cost effective.
Gorren Low and colleagues from University of Southern California and David Geffen School of Medicine, Los Angeles, CA, and Georgetown University School of Medicine, Washington, D.C., have published a comprehensive review of the recent medical literature to evaluate the potential for reducing illness caused by HPV infection and the cost-effectiveness of expanding routine HPV vaccination to include young males. They present their recommendations in the article, "Can Male Vaccination Reduce the Burden of Human Papilloma-Related Disease in the United States?"
Both females and males can transmit HPV and both can become infected and develop genital warts. Reducing the risk of cervical cancer in women has been the main focus of education, marketing, and immunization campaigns associated with the introduction of two effective HPV vaccines. The question now is whether to expand that effort to encourage vaccination among males.
"The authors have dissected the public health, social, ethical, marketing, and economic implications of including of males in HPV vaccination programs," says David L. Woodland, PhD, editor-in-chief of Viral Immunology and chief scientific officer for the Keystone Symposia on Molecular and Cellular Biology. "The data reviewed in this superb paper will be of considerable interest for public health professionals, vaccine researchers, and physicians alike."
Â
Â
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Sharps Safety Starts with Us: Why Infection Preventionists Must Lead the Charge
July 28th 2025Sharps injuries remain a silent but serious threat in health care that infection preventionists are uniquely equipped to confront. With underreporting widespread and safety devices underused, it’s time for IPs to step into a leadership role, using their expertise in systems thinking, education, and policy to build a culture where staff protection is as prioritized as patient care.
US Withdrawal From UNESCO Signals a Dangerous Step Back for Global Science
July 22nd 2025In a decision heavy with consequence and light on foresight, the US has once again chosen to walk away from UNESCO, leaving behind not just a seat at the table, but a legacy of global scientific leadership that now lies in question.
Telemedicine's Transformative Role in PPE Distribution and Sterile Equipment Management
July 22nd 2025In an era defined by digital transformation and post-pandemic urgency, telemedicine has evolved beyond virtual visits to become a vital infrastructure for delivering personal protective equipment (PPE) and managing sterile supplies. By enabling real-time forecasting, remote quality control, and equitable distribution, telemedicine is revolutionizing how health care systems protect both patients and providers.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.